| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.05 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.05 |
| mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.05 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.05 |
| mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |